A Study to Evaluate the Efficacy and Safety of Eculizumab in Guillain-Barré Syndrome
Clinical trial NCT04752566 · COMPLETED
Trial details
- NCT number
- NCT04752566
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-08
- Primary completion
- 2022-08-03
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.